CCR2 and cardiomyopathy: During the development of des-/- cardiomyopathy, Galectin-3 deficiency downregulated CCR2, Arg1 and pro-fibrotic gene expression as well as amelioration of poor cardiac remodeling, inflammation and failure (13).